| scholarly article | Q13442814 |
| P50 | author | Tsutomu Chiba | Q113754504 |
| P2093 | author name string | Norihiko Watanabe | |
| Masahiro Kido | |||
| Nobuhiro Aoki | |||
| Hisayo Nishiura | |||
| Aki Ikeda | |||
| Satoru Iwamoto | |||
| Ryutaro Maruoka | |||
| P2860 | cites work | Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells | Q24563090 |
| Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis | Q27489815 | ||
| Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice | Q28201627 | ||
| The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis | Q29617049 | ||
| Diagnosis and management of autoimmune hepatitis | Q34118165 | ||
| Distinct Licensing of IL-18 and IL-1β Secretion in Response to NLRP3 Inflammasome Activation | Q34428297 | ||
| The impact of ethnicity on the natural history of autoimmune hepatitis | Q34664271 | ||
| Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice | Q34695489 | ||
| CXCR3 in T cell function | Q34726782 | ||
| C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. | Q34967101 | ||
| Molecular mechanisms regulating Th1 immune responses | Q35034059 | ||
| Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. | Q35056090 | ||
| Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus | Q35566819 | ||
| Early Th1 cell differentiation is marked by a Tfh cell-like transition | Q35630458 | ||
| Interleukin-18: recent advances | Q35953062 | ||
| Chemokine receptor CXCR3: an unexpected enigma | Q36241739 | ||
| Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. | Q36281248 | ||
| Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. | Q36369807 | ||
| CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. | Q36677670 | ||
| Interleukin-18 and the pathogenesis of inflammatory diseases | Q36750958 | ||
| IL-1, IL-18, and IL-33 families of cytokines | Q37211243 | ||
| CXCL10 and autoimmune diseases | Q37357428 | ||
| IL-18 and skin inflammation | Q37414506 | ||
| CXCR3, inflammation, and autoimmune diseases. | Q37598305 | ||
| New insights into the differentiation and function of T follicular helper cells. | Q37621244 | ||
| Prognosis of autoimmune hepatitis showing acute presentation | Q43886957 | ||
| Splenectomy Prolongs the Effects of Corticosteroids in Mouse Models of Autoimmune Hepatitis | Q44131631 | ||
| TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression | Q45729201 | ||
| CXCL10 regulates liver innate immune response against ischemia and reperfusion injury | Q46880127 | ||
| Leptin enhances the secretion of interleukin (IL)-18, but not IL-1β, from human monocytes via activation of caspase-1. | Q54299842 | ||
| Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression | Q54753387 | ||
| Dysregulated Generation of Follicular Helper T Cells in the Spleen Triggers Fatal Autoimmune Hepatitis in Mice | Q62735489 | ||
| The nature and prognostic implications of autoimmune hepatitis with an acute presentation | Q72631955 | ||
| Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice | Q73065691 | ||
| Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis | Q73223349 | ||
| Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure | Q78024523 | ||
| Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease | Q78601709 | ||
| Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling | Q81693645 | ||
| Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes | Q83578896 | ||
| IFN-γ is reciprocally involved in the concurrent development of organ-specific autoimmunity in the liver and stomach | Q85088064 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| autoimmune hepatitis | Q786844 | ||
| P304 | page(s) | 224-236 | |
| P577 | publication date | 2014-05-28 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice | |
| P478 | volume | 60 |
| Q26753195 | Adaptive immunity in the liver |
| Q48134030 | Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients |
| Q92314377 | Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies |
| Q36770339 | Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1. |
| Q97885873 | CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients |
| Q37429985 | CXCL9: evidence and contradictions for its role in tumor progression |
| Q38285331 | Cell mediators of autoimmune hepatitis and their therapeutic implications |
| Q99613002 | Circular RNAs associated with a mouse model of concanavalin A-induced autoimmune hepatitis: Preliminary screening and comprehensive functional analysis |
| Q91705300 | Diammonium Glycyrrhizinate Mitigates Liver Injury Via Inhibiting Proliferation Of NKT Cells And Promoting Proliferation Of Tregs |
| Q39173899 | Effect of a post-weaning diet supplemented with functional feed additives on ileal transcriptome activity and serum cytokines in piglets challenged with lipopolysaccharide. |
| Q86252745 | Elevated circulating CD14lowCD16+ monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization |
| Q38730872 | Evolving paradigm of treatment for autoimmune hepatitis |
| Q28069584 | Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models? |
| Q49405029 | Influence of TBX21 T-1993C variant on autoimmune hepatitis development by Yin-Yang 1 binding |
| Q43214205 | Interleukin-18 increases TLR4 and mannose receptor expression and modulates cytokine production in human monocytes |
| Q37017406 | Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis |
| Q50127735 | Myeloid Cells and Chronic Liver Disease: a Comprehensive Review |
| Q89216397 | PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma |
| Q64079995 | Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers |
| Q48156075 | Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis |
| Q91967755 | The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression |
| Q38496935 | Transitioning from Idiopathic to Explainable Autoimmune Hepatitis |
Search more.